ICOS CORP|4Jan 30, 5:38 PM ET

ICOS CORP 4

4 · ICOS CORP · Filed Jan 30, 2007

Form 4

Period: 2007-01-29

DirectorChairman, CEO & President

Transactions

Disposition to Issuer
Stock Options (right to buy)
2007-01-29$9.11/sh−155,000$1,412,050→ 0 total
Exercise: $24.89From: 2006-01-24Exp: 2016-01-23→ Common Stock (155,000 underlying)
Disposition to Issuer
Stock Options (right to buy)
2007-01-29$8.62/sh−250,000$2,155,000→ 0 total
Exercise: $25.38From: 2005-01-27Exp: 2015-01-27→ Common Stock (250,000 underlying)
Disposition to Issuer
Stock Options (right to buy)
2007-01-29$3.69/sh−20,009$73,783→ 0 total
Exercise: $30.31From: 2000-01-05Exp: 2010-01-05→ Common Stock (20,009 underlying)
Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−199,983$6,799,422→ 0 total
Disposition to Issuer
Stock Options (right to buy)
2007-01-29$4.26/sh−370,200$1,577,052→ 0 total
Exercise: $29.74From: 2002-12-12Exp: 2012-12-12→ Common Stock (370,200 underlying)
Disposition to Issuer
Stock Options (right to buy)
2007-01-29$3.69/sh−17,500$64,531→ 0 total(indirect: By Partnership)
Exercise: $30.31From: 2000-01-05Exp: 2010-01-05→ Common Stock (17,500 underlying)
Disposition to Issuer
Stock Options (rights to buy)
2007-01-29$10.57/sh−300,000$3,171,000→ 0 total
Exercise: $23.43From: 2002-05-16Exp: 2012-05-16→ Common Stock (300,000 underlying)

Footnotes (3)

[F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 169,850 shares of unvested restricted stock.
[F2]The options vested monthly in 1/48th increments over four years (48 months) commencing on the grant date indicated.
[F3]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.

Documents

1 file